Jean Coutu's generic drug division drives down profit

Net income for the pharmacy retailer dips $3.5 million year over year

Jean Coutu Group is reporting higher first-quarter revenue but lower profit compared with last year, mostly because of its generic drug manufacturing division.

The Quebec-based pharmacy retailer had $45.5 million of net income in the quarter.

That's down from $49 million in the comparable period last year.

Jean Coutu said the reduced profit was primarily due to a lower contribution from the Pro Doc's generic drug business following a regulatory change that took effect in January.

Overall revenue increased to $750.4 million from $723.6 million a year earlier, mostly because of overall market growth.

The quarterly report was issued ahead of Jean Coutu's annual meeting in Varennes, Que., at the company's head office.

This ad will auto-close in 10 seconds